MG series Disposable Hemoperfusion Cartridge has the ability to absorb macromolecular toxins and protein binding toxoids in the body of patients with end-stage renal disease (ESRD). Combined with hemodialysis treatment, it can reduce the symptoms of complications of patients and improve their quality of life.
Indication：
Adaptation department：
Main features of the product：
Specification and model：
SSCP
MG Hemoperfusion Cartridge is mainly used to treat renal failure, chronic kidney disease, uremia and maintain complications related to hemodialysis, such as renal osteopathy, refractory skin itching, peripheral neuropathy, cardiovascular disease, refractory hypertension and renal encephalopathy.
No absolute contraindications. Use with caution in patients with severe thrombocytopenia, hemocytopenia, or other clotting disorders.
MG150: adsorbent volumn 150mL
MG250: adsorbent volumn 250mL
MG350: adsorbent volumn 350mL
